期刊文献+

冠心病合并2型糖尿病心功能不全B型钠尿肽的变化 被引量:1

Change of BNP Level of Coronary Heart Disease Complicated with T2DM Heart Function Incomplete
原文传递
导出
摘要 目的探讨冠心病合并2型糖尿病心功能不全血浆B型钠尿肽水平(BNP)变化的意义。方法采用免疫荧光法测定63例冠心病合并2型糖尿病心功能不全(观察组)及62例冠心病心功能不全患者(对照组)血浆的BNP水平,并用心脏超声测定左室射血分数(LVEF)数值,以了解左心室功能,然后对两组数据进行临床对比分析。结果观察组BNP水平明显高于对照组,而观察组LVEF值低于对照组(P<0.05)。观察组住院时间更长。结论观察组BNP水平、LVEF值与对照组比较有统计学意义。因此,对冠心病合并2型糖尿病心功能不全患者,可以通过血浆BNP水平的测定,早期准确地诊断心力衰竭及判断心衰分级,以利于临床上及时有效地调整治疗方案,尽早纠正心衰,缩短住院时间,减少病死率。 Objective To explore the significance of change of BNP Level of coronary heart disease(CHD) complicated with T2 DM heart function incomplete.Methods Adopt immuuno Lucent method to check the patients plasma BNP Level of 63 cases CHD complicated with T2 DM heart function incomplete(observation group) and 62 cases CHD heart function incomplete(control gronp) and Use cardioultrasound to measure LVEF to know the function of left ventricular,then contrast analyze the two groups data.Results The BNP level of observation group is obviously higher than that of control group,while the LVEF value of the observation group is lower than that of control group(P0.05),observation group's hospitalization time is longer.Conclusion There's obvious difference among the two group's BNP level and LVEF value,so the measure of plasma BNP level can early accurately diagnose the degree of heart failure which is beneficial for timely adjusting therapy scheme,to rectify heart failure early,shorten hospitalization time and lessen mortality.
作者 张友生
出处 《医药论坛杂志》 2010年第6期14-15,共2页 Journal of Medical Forum
关键词 冠心病合并2型糖尿病 冠心病 血浆B型钠尿肽 心力衰竭 CHD complicated with T2DM CHD BNP Heart failure
  • 相关文献

参考文献6

  • 1Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for diagnosis and treatment of non - ST - segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non - ST - Segment Elevation Acute Coronary Syndromes of the Europaan Society of Cardiology [J]. Eur Heart J, 2007,28 ( 13 ) : 1598- 1660.
  • 2Executive Summary of The Third Report of The National Cholesterol Education Program(NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel Ⅲ) [J]. JAMA ,2001,16,285 (19) :2486-2497.
  • 3Bartnik M, Ryden L Ferrzri R. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart [J]. Eur - Heart J,2004,25 (21) : 1880-1890.
  • 4曾春来,韦铁民.B型钠尿肽及其在心血管疾病中的临床应用[J].心脑血管病防治,2003,3(6):47-50. 被引量:7
  • 5Anand IS, Fisher LD, Chiang YT,et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Hrat Failure Trial ( Val - HEFT) [ J ]. Circulation ,2003,107 (9) : 1278-1283.
  • 6Maurellet JD,Liu PT. B - type natriuretic peptide in the management of Heart Failure [J]. Hong Kong Med J, 2008,14( 3 ) :216-219.

二级参考文献25

  • 1[10]Charron F,Paradis P,Bronchain O,et a1.Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression.Mol Cell Bio1,1999,19(6):4355-4365.
  • 2[11]Suga S,Nakao K,Hosoda K,et al,Receptor selectivity of natriuretic peptide family,atrial natriuretic peptide,brain natriuretic peptide,and C-type natriuretic peptide.Endocrinology,1992,130(1):229-239.
  • 3[12]Grantham JA,Borgeson DD,Burnett JC.BNP:pathophysiological and potential therapeutic roles in acute congestive heart failure.Am J Physiol,1997,92(2):R1077-1083.
  • 4[13]Brunner-La Rocca HP,Kaye DM,Woods RL,et al.Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compard with healthy control subjects.JACC,2001,37(5):1221-1227.
  • 5[14]Burrell LM,Lambert HJ,Baylis BH.Effect of atrial natriuretic peptide on thirst and arginine vasoperssin release in humans.Am J Physiol,1991,260(2):R475-479.
  • 6[15]Cao L,Gardner DG.Natriuretic peptides inhibit DNA Synthesis in cardial fibroblasts.Hypertension,1995,25(2):227-234.
  • 7[16]Haug C,Metzele A,Steffen J,et al.Increased brain natriuretic peptide and atrail peptide plasma concentration in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.Clin Invest,1994,72(6):430-434.
  • 8[17]Kikuta K,Yasue H,Yoshimura M,et al.Increased plasma levels of B-type natriuretic peptide in patients with unstable angina.Am Heart J,1996,132(1):101-107.
  • 9[18]Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N Eng1 J Med,2002,347(3):161-167.
  • 10[19]McDonagh TA,Morrison CE,Lawrence A,et al.Symptomatic and asymptomatic leftventricular systolic dysfunction in an urban population.Lancet,1997,350(9081):829-833.

共引文献6

同被引文献20

  • 1陈忠,马根山,冯毅,罗丹,严金川,沈成兴,戴启明,丁建东.不同类型冠心病病人血浆脑钠肽检测及其意义[J].中国急救医学,2005,25(4):253-254. 被引量:14
  • 2贾永平,王凤群,吕吉元,高宇平,王睿,郭志萍,刘春花.脑钠尿肽与冠状动脉病变严重程度的相关性研究[J].中国民康医学,2005,17(11):647-649. 被引量:1
  • 3Sudoh T, Kangawa N, Minamion N, et al. A new natriuretic peptide in porcine brain [J]. Natre, 1998,3,32:78 - 81.
  • 4WieczorekSJ,Wu AH ,Christenson R,etal. A rapid B -type natri uretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation[J]. Am Heart J, 2002,144(5):834.
  • 5Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B- type na triuretic peptide in the diagnosis of congestive heart failure in an urgent - care setting[J]. J Am Coll Cardiol, 2001,37 (2): 379.
  • 6Yasue H,Yoshimura M,Sumida H,et al. Localization and mechanism of secretion of B - type natriuretic peptide in comparison with those of Aytpe natriuretic peptide in normal subjects and patients with heart failure[J]. Circulation,1994,90(1) :195.
  • 7Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third re port of the national cholesterol education program(NCEP) expert pane/on detection, evaluation, and treatment of high blood cho lesterol in adults(adult treatment panel Ⅲ)[J]. JAMA, 2001,16, 285(19):2486 - 2497.
  • 8Bartnik M, Ryden L Ferrari R. The prevalence of abnormal glu cose regulation in patients with coronary artery disease across Eu rope. The Euro heart survey on diabetes and the heart [J]. Eur Heart J,2004,25(21):1880 - 1890.
  • 9Murdoeh DR, Mcdonagh TA, Byme J, et al. Titration of vasodila tor therapy in chronic heart failure according to plasma brain na triuretic peptide concentration:Randomized comparison of the he modynamic and neuroendocrine effects of tailored versus empiri cal therapy[J]. Am Heart J,1999,138(126) :1126.
  • 10DeLemos JA, Morrow DA , Bentley J H, et al. The prognostic value of B- type natriuretic peptide in patients with acute coronary syndromes[J]. N Engl Med,2001,345 (14):1014 - 1021.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部